Press Releases Filter Options Archive DateYear20262025202420232022202120202019201820172016201520142013201220112010200920082007MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember View 12 View 12View 24View 48 Categories CorporateFinancialPrescription MedicinesResearch and PipelineSocial ResponsibilityVaccines Keywords All Keywords Covid-19FinanceInvestmentsLeadershipMedicinesPartnershipsResearchResponsibilityVaccines September 2022 09.14.2022 Pfizer Initiates Phase 3 Study of mRNA-Based Influenza VaccineResearch and PipelineResearch August 2022 08.08.2022 Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15Research and PipelineResearch June 2022 06.17.2022 Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated PainResearch and PipelineResearch Page 1 Page 2 Page 3 Page 4 Current page 5
